These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 232662)

  • 1. [Pharmacologic effects of the antihypertensive 6-benzoyl-3-hydrazino-5,6,7,8-tetrahydropyrido[4,3-c]pyridazine (BQ 22-708, endralazine)].
    Salzmann R; Bürki H; Chu D; Clark B; Marbach P; Markstein R; Reinert H; Siegl H; Waite R
    Arzneimittelforschung; 1979; 29(12):1843-53. PubMed ID: 232662
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bicyclic 3-hydrazinopyridazines with antihypertensive action (author's transl)].
    Schenker E; Salzmann R
    Arzneimittelforschung; 1979; 29(12):1835-43. PubMed ID: 546422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678).
    Baum T; Shropshire AT; Rowles G; Van Pelt R; Fernandez SP; Eckfeld DK; Gluckman MI
    J Pharmacol Exp Ther; 1970 Feb; 171(2):276-87. PubMed ID: 5466490
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Antihypertensive activity of a new 3-hydrazinopyridazine derivative: ISF 2123.
    Carpi C; Dorigotti L
    Br J Pharmacol; 1974 Nov; 52(3):459P. PubMed ID: 4458870
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of 3-hydrazino-6[N, N-bis (2-hydroxyethyl) amino]-pyridazine (L 6150) on renin in hypertensive rats.
    Kawashima K; Watanabe TX; Sokabe H
    Jpn J Pharmacol; 1980 Feb; 30(1):116-8. PubMed ID: 6995653
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mechanism of action of a new hypotensive agent: 3-hydrazino-6-(N,N-bis-(2-hydroxyethyl)-amino)-pyridazine chlorhydrate (L 6150)].
    Baldoli E; Sardi A; Caravaggi AM; Bianchi G
    Boll Chim Farm; 1972 Aug; 111(8):480-8. PubMed ID: 4647088
    [No Abstract]   [Full Text] [Related]  

  • 7. [Derivatives of pyridazine. 5. Synthesis and antihypertensive activity of 6-phenyl-5-morpholinylmethyl-3-hydrazino pyridazines].
    Orallo F; Calleja JM; García Mera G; Raviña E
    Arch Farmacol Toxicol; 1985 Dec; 11(3):171-82. PubMed ID: 4096551
    [No Abstract]   [Full Text] [Related]  

  • 8. Flavodilol: a new antihypertensive agent that preferentially depletes peripheral biogenic amines.
    Blosser JC; McCreedy S; Parker RB; Kinsolving CR; Watkins BE; Wu ES
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):142-56. PubMed ID: 2475706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive mechanisms of beta-adrenoceptor blockade: a review.
    van Baak MA; Struyker Boudier HA; Smits JF
    Clin Exp Hypertens A; 1985; 7(1):1-72. PubMed ID: 2859936
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of three metabolites of 3-hydrazino-6-[bis-(2-hydroxyethyl)amino]pyridazine. A new rearrangement of 3-[1-methylethyliden)hydrazino] derivative.
    Bellasio E; Campi A
    Farmaco Sci; 1978 Aug; 33(8):565-72. PubMed ID: 744255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cadralazine on systemic blood pressure, renal function and plasma renin activity in anesthetized dogs.
    Yukimura T; Miura K; Tanaka M; Higashio T; Sakaguchi S; Kuroda K; Yamamoto K
    Arzneimittelforschung; 1988 Jan; 38(1):25-8. PubMed ID: 3284531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridazine derivatives, VIII: Synthesis and antihypertensive activity of 6-(2-thienyl)-5-aminomethyl-3-hydrazino-pyridazines.
    Ravina E; Teran C; Dominguez NG; Masaguer CF; Gil-Longo J; Orallo F; Calleja JM
    Arch Pharm (Weinheim); 1991 Jul; 324(7):455-60. PubMed ID: 1763955
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autoradiographic studies of the distribution of 14C-endralazine in the mouse].
    Kindler J; Mödder G; Sieberth HG
    Arzneimittelforschung; 1985; 35(3):599-602. PubMed ID: 4039585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, hypotensive and diuretic activities of several 3-hydrazino-5,6-dihydrobenzo[h]cinnolines. Part 10: Pyridazine derivatives.
    Ravina E; Fueyo J; Teran C; Cid J; Garcia Mera G; Orallo F; Bardan B
    Pharmazie; 1992 Aug; 47(8):574-7. PubMed ID: 1438508
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological actions of N-(2-o-methoxyphenoxyethyl)-6,7-dimethoxy-3,4-dihydro-2-(1H)-isoquinoline carboxamidine hydrobromide (SC-3123).
    Ferrini R; Miragoli G; Santarelli G
    Boll Chim Farm; 1972 Jun; 111(6):353-65. PubMed ID: 4403255
    [No Abstract]   [Full Text] [Related]  

  • 16. General pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: Effects on cardiovascular, visceral and renal functions and on blood.
    Matsuno Y; Taira N; Fujitani B; Ito T; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):55-62. PubMed ID: 3513777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, a new, antihypertensive substance].
    Hoefke W; Kobinger W
    Arzneimittelforschung; 1966 Aug; 16(8):1038-50. PubMed ID: 6014885
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of drug preparation no. 18 on the cardiovascular system.
    Vlakhov V
    Nauchni Tr Vissh Med Inst Sofiia; 1966; 45(5):51-60. PubMed ID: 4228992
    [No Abstract]   [Full Text] [Related]  

  • 19. The dominance of adrenergic mechanisms in mediating hypotensive drug-induced renin release in the conscious rat.
    Keeton TK; Pettinger WA
    J Pharmacol Exp Ther; 1979 Feb; 208(2):303-9. PubMed ID: 762664
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and biological properties of pyrido [2, 3-d] pyridazine derivatives.
    Kuczyński L; Mrozikiewicz A; Banaszkiewicz W; Respond S
    Pol J Pharmacol Pharm; 1982; 34(4):223-8. PubMed ID: 7182843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.